SCHEMBL4469707

SCHEMBL4469707

Cc1cc(N)ccc1N1CCOCC1=S

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
ALDH1A1 P00352 6/20 0.47
GAA P10253 3/20 0.47
MEN1 O00255 2/20 0.47
THRB P10828 2/20 0.47
KMT2A Q03164 2/20 0.47
NR4A1 P22736 1/20 0.47
PTK2B Q14289 1/20 0.47
KDM4E B2RXH2 4/20 0.44
ALOX15 P16050 2/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
RAD52 P43351 2/20 0.42
GFER P55789 1/20 0.42
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RAF1 P04049 2/20 0.34
BRAF P15056 2/20 0.34
F10 P00742 3/20 0.34
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77090 0.82 MAPT (0.47) MAPTALDH1A1GAAMEN1THRB
SCHEMBL5631995 0.78 MAPT (0.57) MAPTALDH1A1GAAMEN1THRB
SCHEMBL3866106 0.76 ALDH1A1 (0.60) MAPTALDH1A1GAAMEN1THRB
SCHEMBL519230 0.76 MAPT (0.69) MAPTALDH1A1GAAMEN1THRB
SCHEMBL3750305 0.75 MAPT (0.46) MAPTALDH1A1GAAMEN1THRB
SCHEMBL5514263 0.74 F10 (0.53) F10
SCHEMBL5502392 0.72 F10 (0.43) GAAF10
SCHEMBL5388815 0.72 MAPT (0.50) MAPTALDH1A1GAAMEN1THRB
SCHEMBL15358737 0.69 MAPT (0.81) MAPTALDH1A1GAAMEN1THRB
SCHEMBL520105 0.68 MAPT (0.47) MAPTALDH1A1GAAMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476663-B2 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-13 US disclosed
EP-1747217-A1 NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2007-01-31 EP disclosed
US-20050277628-A1 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-15 US disclosed
WO-2005111029-A1 NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277628-A1 Substituted thiophene carboxamides OTC, SLC22A8, DDC MAPT 341/4885ALDH1A1 910/4885GAA 3096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.